Nomura dropped the price target on PB Fintech from ₹1,590 to ₹1,100 on Thursday. That’s a 31% haircut. The brokerage kept its "neutral" rating, but the math changed drastically—upside potential from Wednesday’s close is now just 5.8%.
The structural damage comes from the Insurance Regulatory and Development Authority of India (IRDAI) guidelines released on September 23. The regulator proposed cutting commissions by up to two-thirds in health, term, and motor insurance segments. Nomura’s note assumes PB Fintech exits its point-of-sales (POS) person business entirely. Consequently, net profit estimates for FY28 and FY29 were slashed by 72% and 51%, while total expenses were revised down by 40% and 48% for those years.
The market reacted violently to the regulatory shift. PB Fintech shares tumbled 48.2% over seven consecutive trading sessions following the IRDAI announcement. On October 1, the stock breached its IPO price of ₹980, erasing five years of gains. The bleeding slowed recently, with the stock recovering 6% on Tuesday, October 6, and closing 0.5% higher at ₹1,040.1 on Wednesday, October 7.
Nomura’s cash flow outlook also tightened. The firm now projects a Cash Flow CAGR of 13.2% for FY26-FY30, down from the earlier 15.1% estimate. PolicyBazaar, Dubai, and corporate segments remain untouched in the model, but the core insurance distribution engine is under regulatory pressure. Investors are watching if the stock can consolidate near ₹1,040 or if further margin compression tests support levels.